What Is the Dislocation and Revision Rate of Dual-mobility Cups Used in Complex Revision THAs?

Niklas Unter Ecker1,2,3, Hakan Kocaoğlu1,2,3, Akos Zahar1,2,3

  • 1N. U. Ecker, H. Kocaoğlu, C. Haasper, T. Gehrke, M. Citak, Department of Orthopaedic Surgery, Helios ENDO-Klinik Hamburg, Hamburg, Germany.

Insights

Dual-mobility cups in complex revision total hip arthroplasty (THA) showed higher dislocation rates than anticipated. Careful consideration is advised for cases with significant bone or soft-tissue loss.

Area of Science:

  • Orthopedic surgery
  • Arthroplasty
  • Biomaterials

Background:

  • Dual-mobility cups (DMCs) are recognized for reducing dislocation risk in total hip arthroplasty (THA).
  • Their efficacy in complex revision THA, particularly with extensive bone/soft-tissue loss or multiple prior surgeries, remains less studied.
  • This study evaluates DMCs in challenging revision THA scenarios.

Purpose of the Study:

  • To determine the survival rate free from revision for dislocation of DMCs in complex revision THA.
  • To assess the overall survival rate free from any dislocation in these patients.

Main Methods:

  • A cohort of 327 patients undergoing complex revision THA with DMCs between 2009-2013 was analyzed.
  • Complex revision was defined by criteria including significant bone loss, soft-tissue involvement, or multiple prior procedures.
  • Kaplan-Meier survival analysis was performed on 216 patients with a median follow-up of 69 months.

Main Results:

  • Dislocation-free survival was 96% at 5 years and 82% at 9 years.
  • Survival free from revision for dislocation was 99% at 5 years and 85% at 9 years.
  • The overall dislocation rate was 11% at the final follow-up.

Conclusions:

  • Dual-mobility cups in this complex revision THA cohort exhibited higher dislocation and revision rates than previously reported.
  • While DMCs remain a primary option for instability, cautious use is recommended in cases of severe bone loss or soft-tissue compromise.
  • Further research is needed to optimize outcomes in these challenging patient populations.
Abstract

Related Concept Videos